RE:RE:Adstiladrin has BlockBuster Potential...Probably not a great comparison on a few fronts. The 500 million dollar deal was to a multi product multi national company that has bricks and mortar in many countries. They've also been in business for 70 years. They had the global infrastructure in place. The 500 million is for a piece of the action. At 160k-260k a treatment they have a huge revenue potential. They had the product AND the infrastructure to negotiate that deal. Theralase does not have that same footprint. They do however have a great product. When approved they will be bought IMO. A JV makes no sense to me. At this stage of the game big pharma would want to control everything. When it's approved what does Theralase bring to the table other than a great product. Not downplaying the amazing job Theralase has done on a shoestring budget. Price will be a product of efficacy, ease of manufacturing and safety. Theralase seems to be hitting home runs on all three.